NM 0127Alternative Names: METDoloron; NM-0127
Latest Information Update: 28 Jul 2016
At a glance
- Originator Nanomerics
- Class Analgesics; Opioid peptides
- Mechanism of Action Opioid delta receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Neuropathic pain
Most Recent Events
- 28 Jul 2016 Phase-I clinical trials in Neuropathic pain in United Kingdom (unspecified route)